DrugPatentWatch Database Preview
« Back to Dashboard
Summary for Patent: 4,404,216
|Title:||Antifungal 1,3-bis-triazolyl-2-propanol derivative|
|Abstract:||2-(2,4-Difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol and its pharmaceutically acceptable acid addition salts are disclosed. This particular bis-triazole derivative and its aforesaid salts are useful for treating fungal infections in animals, including humans. Methods for preparing these compounds from known starting materials are provided.|
|Inventor(s):||Richardson; Kenneth (Canterbury, GB2)|
|Assignee:||Pfizer Inc. (New York, NY)|
|Patent Litigation and PTAB cases:||See patent lawsuits and PTAB cases for patent 4,404,216|
1. An antifungal compound selected from the group consisting of 2-(2,4-difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol and the pharmaceutically acceptable acid addition salts
2. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and an effective antifungal amount of a compound as claimed in claim 1.
3. A method for treating fungal infections in a warm-blooded animal, which comprises administering to said animal an effective antifungal amount of a compound as claimed in claim 1.
For more information try a trial or see the plans and pricing
Serving hundreds of leading biopharmaceutical companies globally: